GROSSI, Laurino
 Distribuzione geografica
Continente #
EU - Europa 322
NA - Nord America 76
AS - Asia 48
AF - Africa 6
SA - Sud America 2
OC - Oceania 1
Totale 455
Nazione #
FR - Francia 223
US - Stati Uniti d'America 76
IT - Italia 61
IE - Irlanda 14
VN - Vietnam 11
IN - India 9
GB - Regno Unito 7
ID - Indonesia 5
LB - Libano 5
CN - Cina 4
UA - Ucraina 4
HR - Croazia 3
JO - Giordania 3
TW - Taiwan 3
BH - Bahrain 2
EG - Egitto 2
FI - Finlandia 2
IR - Iran 2
NL - Olanda 2
RO - Romania 2
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
DE - Germania 1
EC - Ecuador 1
ES - Italia 1
ET - Etiopia 1
IL - Israele 1
JP - Giappone 1
NG - Nigeria 1
PH - Filippine 1
SE - Svezia 1
TR - Turchia 1
UG - Uganda 1
ZM - Zambia 1
Totale 455
Città #
Paris 50
Chieti 32
Ashburn 17
Dublin 14
Boardman 12
Columbus 10
Dong Ket 10
Milan 8
New York 6
Rome 6
Beirut 5
Amman 3
Corbeil-Essonnes 3
Council Bluffs 3
London 3
Makassar 3
San Jose 3
Taipei 3
Atlanta 2
Bucharest 2
Diyarb Najm 2
Helsinki 2
Kolkata 2
Manama 2
Mountain View 2
Naples 2
Napoli 2
Pune 2
Queens 2
Rotherham 2
Varallo 2
Zagreb 2
Allentown 1
Amsterdam 1
Ann Arbor 1
Catania 1
Chennai 1
Chicago 1
Dallas 1
Dalmine 1
Delhi 1
Desio 1
Guayaquil 1
Ho Chi Minh City 1
Holon 1
Houston 1
Isfahan 1
Jakarta 1
Kampala 1
Karlovac 1
Kettering 1
Kyiv 1
La Paz 1
Lawrence 1
Livingston 1
Los Angeles 1
Lusaka 1
Marseille 1
Melbourne 1
Mesra 1
Miami 1
Nuremberg 1
Pescara 1
Phoenix 1
Pleven 1
Port Harcourt 1
Rimini 1
San Juan Pequeno 1
Seattle 1
Shenyang 1
Stockholm 1
Sunset 1
Tehran 1
Toledo 1
Verona 1
Ōita 1
Totale 263
Nome #
Ottimizzazione di vedolizumab in RCU con perdita di risposta a infliximab, file e4233f17-173f-2860-e053-6605fe0a460a 209
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study, file e4233f19-64e7-2860-e053-6605fe0a460a 49
Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment of Helicobacter pylori Infection: Two Pilot Studies., file e4233f19-43c8-2860-e053-6605fe0a460a 33
ESOPHAGITIS AND ITS CAUSES: WHO IS "GUILTY" WHEN ACID IS FOUND "NOT GUILTY"?, file e4233f15-fe39-2860-e053-6605fe0a460a 29
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy, file e4233f19-7728-2860-e053-6605fe0a460a 21
TWO-YEAR EFFECTIVENESS AND SAFETY OF GOLIMUMAB IN ULCERATIVE COLITIS: AN IG-IBDSTUDY., file e4233f18-c2ab-2860-e053-6605fe0a460a 17
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study, file e4233f18-8ead-2860-e053-6605fe0a460a 14
Influence of the COVID-19 Outbreak on Disease Activity and Quality of Life in Inflammatory Bowel Disease Patients, file e4233f18-9d4d-2860-e053-6605fe0a460a 14
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis, file e4233f17-f6b2-2860-e053-6605fe0a460a 11
Fabric Phase Sorptive Extraction-High Performance Liquid Chromatography-Photo Diode Array Detection Method for Simultaneous Monitoring of Three Inflammatory Bowel Disease Treatment Drugs in Whole Blood, Plasma and Urine, file e4233f19-64e8-2860-e053-6605fe0a460a 10
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: The IG-IBD LIVE study, file e4233f19-75a1-2860-e053-6605fe0a460a 9
Fabric Phase Sorptive Extraction-High Performance Liquid Chromatography-Photo Diode Array Detection Method for Simultaneous Monitoring of Three Inflammatory Bowel Disease Treatment Drugs in Whole Blood, Plasma and Urine, file e4233f16-aa29-2860-e053-6605fe0a460a 8
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy, file e4233f15-b228-2860-e053-6605fe0a460a 6
SPONTANEOUS OPENING OF LES IN ACHALASIA: AN UNCOMMON ON-LINE DOCUMENTATION BY HIGH-RESOLUTION MANOMETRY, file e4233f15-fe37-2860-e053-6605fe0a460a 6
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study, file e4233f18-8ecc-2860-e053-6605fe0a460a 6
null, file e4233f19-64e5-2860-e053-6605fe0a460a 4
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey, file e4233f19-761d-2860-e053-6605fe0a460a 4
H2-RECEPTOR ANTAGONISTS ARE SCAVENGERS OF OXYGEN RADICALS, file e4233f15-89f4-2860-e053-6605fe0a460a 2
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study, file e4233f19-64e6-2860-e053-6605fe0a460a 2
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance., file e4233f14-f892-2860-e053-6605fe0a460a 1
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care, file e4233f18-3998-2860-e053-6605fe0a460a 1
Totale 456
Categoria #
all - tutte 1.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.539


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 5 0 0 0 2 0 1 0 0
2020/202115 0 0 0 1 0 0 0 2 0 0 1 11
2021/202245 4 1 4 1 3 0 3 3 3 1 0 22
2022/202369 0 1 0 2 1 5 19 4 5 1 30 1
2023/2024315 6 9 7 5 11 210 11 8 17 14 17 0
Totale 456